EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R

Overview of attention for article published in Frontiers in Medicine, October 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

policy: 1 policy source

twitter: 10 X users

Citations

dimensions_citation: 41 Dimensions

Readers on

mendeley: 89 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 12 X posts from 10 X users, with an upper bound of 17,388 followers.

@imi_paradigm embarks on updating EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R&D https://t.co/7loO4pxsZl #patientengagement #cookbook

28 Mar 2019

Reply Repost Favourite

PATIENT WHO? The term “patient” is often used as a general, imprecise term that does not reflect the different types of input and experience required from patients, patient advocates and patient organizations... https://t.co/37C0WtIUCv

10 Nov 2018

Reply Repost Favourite

Frontiers | EUPATI guidance for patient involvement in medicines research and development (R&D); Guidance for pharmaceutical industry-led medicines R&D | Medicine https://t.co/3EpqTduIjA

17 Oct 2018

Reply Repost Favourite

Congrats to our #eupati colleagues for this 4th guidance in a set of 4: EUPATI Guidance for Patient Involvement in Medicines R&D; Guidance for Pharmaceutical Industry-Led Medicines R&D https://t.co/ZJfdqx219n

11 Oct 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.